Geron
GERN
#6239
Rank
โ‚ฌ0.73 B
Marketcap
1,16ย โ‚ฌ
Share price
0.00%
Change (1 day)
-58.73%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -โ‚ฌ41.76 Million

According to Geron's latest financial reports the company's current earnings are โ‚ฌ0.18 Billion. In 2024 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ41.76 Million-68.29%
2024 -โ‚ฌ0.14 Billion-11.23%
2023 -โ‚ฌ0.15 Billion30.22%
2022 -โ‚ฌ0.12 Billion20.15%
2021 -โ‚ฌ94.8 Million50.08%
2020 -โ‚ฌ63.17 Million4.46%
2019 -โ‚ฌ60.47 Million130.68%
2018 -โ‚ฌ26.22 Million8.84%
2017 -โ‚ฌ24.09 Million-3.08%
2016 -โ‚ฌ24.85 Million-22080.6%
2015 โ‚ฌ0.11 M-100.38%
2014 -โ‚ฌ30.03 Million-7.14%
2013 -โ‚ฌ32.33 Million
2011 -โ‚ฌ76.49 Million19.04%
2010 -โ‚ฌ64.26 Million8.45%
2009 -โ‚ฌ59.25 Million-2.51%
2008 -โ‚ฌ60.78 Million14.65%
2007 -โ‚ฌ53.02 Million32.68%
2006 -โ‚ฌ39.96 Million25.59%
2005 -โ‚ฌ31.82 Million4.36%
2004 -โ‚ฌ30.49 Million19.73%
2003 -โ‚ฌ25.46 Million-15.46%
2002 -โ‚ฌ30.12 Million1.94%
2001 -โ‚ฌ29.55 Million33.59%
2000 -โ‚ฌ22.12 Million27.53%
1999 -โ‚ฌ17.34 Million63.13%
1998 -โ‚ฌ10.63 Million15.6%
1997 -โ‚ฌ9.2 Million-10.66%
1996 -โ‚ฌ10.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.33 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ1.33 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ58.42 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ97.47 M-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.01 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA